All Stories

  1. Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation

    Article • Clinical Lymphoma Myeloma & Leukemia, April 2020, Elsevier

    Radwan Massoud

  2. The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study

    Article • Current Research in Translational Medicine, April 2020, Elsevier

    Radwan Massoud

  3. Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma

    Article • Leukemia & Lymphoma, February 2020, Taylor & Francis

    Radwan Massoud

  4. Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience

    Article • Clinical Lymphoma Myeloma & Leukemia, October 2019, Elsevier

    Radwan Massoud

  5. Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update

    Article • Clinical Lymphoma Myeloma & Leukemia, August 2019, Elsevier

    Radwan Massoud

  6. Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness

    Article • Nature Communications, June 2019, Springer Science + Business Media

    Radwan Massoud

  7. Haploidentical related donor allogeneic hematopoietic stem cell transplantation for patient aged older than 76 years with refractory acute myeloid leukemia

    Article • Hematology/Oncology and Stem Cell Therapy, December 2018, Elsevier

    Radwan Massoud, Souha Kanj

  8. Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation

    Article • British Journal of Pharmacology, October 2018, Springer Science + Business Media

    Radwan Massoud, Souha Kanj

  9. Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience

    Article • Current Research in Translational Medicine, September 2018, Elsevier

    Radwan Massoud

  10. Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

    Article • August 2018, Elsevier

    Radwan Massoud, Souha Kanj

  11. Thiotepa 10 mg/kg seems superior to Thiotepa 5 mg/kg in the TBF conditioning regimen in patients undergoing allogeneic stem cell transplantation

    Article • Clinical Lymphoma Myeloma & Leukemia, March 2018, Elsevier

    Radwan Massoud

  12. Progressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature

    Article • Current Research in Translational Medicine, November 2017, Elsevier

    Radwan Massoud, Souha Kanj

  13. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation

    Article • Journal of Clinical Virology, October 2017, Elsevier

    Radwan Massoud, Souha Kanj

  14. Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant

    Article • British Journal of Pharmacology, June 2017, Nature

    Radwan Massoud

  15. Trends in hematopoietic stem cell transplant activity in Lebanon

    Article • Hematology/Oncology and Stem Cell Therapy, June 2017, Elsevier

    Radwan Massoud

  16. Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma

    Article • British Journal of Pharmacology, April 2017, Nature

    Radwan Massoud

  17. Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia

    Article • Cancer, April 2017, Wiley

    Radwan Massoud

  18. Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

    Article • British Journal of Pharmacology, April 2017, Nature

    Radwan Massoud

  19. Bendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem cell transplantation

    Article • Leukemia & Lymphoma, March 2017, Taylor & Francis

    Radwan Massoud

  20. Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis

    Article • Clinical Lymphoma Myeloma & Leukemia, March 2017, Elsevier

    Radwan Massoud

  21. Post Transplant Brentuximab Maintenance Appears more Effective than Post Transplant Salvage Brentuximab for Relapsed /Refractory Hodgkin Lymphoma

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2016, Elsevier

    Radwan Massoud

  22. Dynamics of Molecular Response in AML Patients with NPM1 and FLT3 Mutations Undergoing Allogeneic Stem Cell Transplant

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2016, Elsevier

    Radwan Massoud

  23. Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: a Single-Center Study at the American University of Beirut Medical Center (AUBMC)

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2016, Elsevier

    Radwan Massoud